The antigen-presenting cell function of Reed-Sternberg cells.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Leukemia and Lymphoma

• Publication date

  1995-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/10428199509064920PMID 8580827
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• T cells as antigen-presenting cells.

  1994cited by this paper
• In vivo expression of the B7 costimulatory molecule by subsets of antigen-presenting cells and the malignant cells of Hodgkin's disease.

  1994cited by this paper
• Absence of HLA class I expression by Reed-Sternberg cells.

  1994cited by this paper
• Nodular lymphocyte predominance Hodgkin's disease. A distinct clinicopathological entity.

  1994cited by this paper
• The B7 and CD28 receptor families.

  1994cited by this paper
• Cancer antigens: immune recognition of self and altered self

  1994cited by this paper
• Lymphocyte predominance Hodgkin's disease: lineage and clonality determination using a single-cell assay.

  1994cited by this paper
• In situ expression of B7/BB1 on antigen-presenting cells and activated B cells: an immunohistochemical study.

  1993cited by this paper
• B70 antigen is a second ligand for CTLA-4 and CD28

  1993cited by this paper
• Functional expression of B7/BB1 on activated T lymphocytes

  1993cited by this paper
• Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation.

  1993cited by this paper
• The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's disease and contributes to the stimulating capacity of Hodgkin's disease-derived cell lines.

  1993cited by this paper
• Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. Continuous cell lines.

  1993cited by this paper
• Discordant expression of CD28 ligands, BB-1, and B7 on keratinocytes in vitro and psoriatic cells in vivo.

  1993cited by this paper
• B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro

  1993cited by this paper
• Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells.

  1993cited by this paper
• Identification of an alternative CTLA-4 ligand costimulatory for T cell activation.

  1993cited by this paper
• The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's disease and contributes to the stimulating capacity of Hodgkin's disease-derived cell lines

  1993cited by this paper
• CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

  1992cited by this paper
• Role of T cells in the pathogenesis of Hodgkin's disease.

  1992cited by this paper
• Costimulation of T cell receptor/CD3-mediated activation of resting human CD4+ T cells by leukocyte function-associated antigen-1 ligand intercellular cell adhesion molecule-1 involves prolonged inositol phospholipid hydrolysis and sustained increase of intracellular Ca2+ levels.

  1992cited by this paper
• Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4.

  1992cited by this paper
• [Proliferating cells in Hodgkin's disease].

  1992cited by this paper
• The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro.

  1992cited by this paper
• CD2/LFA-3 ligation induces phospholipase-C gamma 1 tyrosine phosphorylation and regulates CD3 signaling.

  1992cited by this paper
• Hodgkin's cells express a novel pattern of adhesion molecules

  1992cited by this paper
• Immunophenotype of Reed-Sternberg cells.

  1992cited by this paper
• The immunohistochemistry of Hodgkin's disease.

  1992cited by this paper
• CTLA-4 is a second receptor for the B cell activation antigen B7

  1991cited by this paper
• Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation

  1991cited by this paper
• Remote T cell co‐stimulation via LFA‐1/ICAM‐1 and CD2/LFA‐3: Demonstration with immobilized ligand/mAb and implication in monocyte‐mediated co‐stimulation

  1991cited by this paper
• Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease.

  1991cited by this paper
• Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway.

  1991cited by this paper
• B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2.

  1991cited by this paper
• The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells

  1991cited by this paper
• Lymphocyte functional antigens stabilize agglutination between Reed-Sternberg cells and T cells, but are not responsible for homotypic binding of Hodgkin's Reed-Sternberg cells.

  1990cited by this paper
• The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease.

  1989cited by this paper
• Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease.

  1989cited by this paper
• Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway.

  1989cited by this paper
• Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization.

  1989cited by this paper
• High numbers of CD4+ T cells showing abnormal recognition of DR antigens in lymphoid organs involved by Hodgkin's disease.

  1988cited by this paper
• Alloantigen presentation by B cells. Requirement for IL-1 and IL-6.

  1988cited by this paper
• Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP

  1988cited by this paper
• Molecular pathways of adhesion in spontaneous rosetting of T-lymphocytes to the Hodgkin's cell line L428.

  1988cited by this paper
• Clonal immunoglobulin gene rearrangements in tissues involved by Hodgkin's disease.

  1987cited by this paper
• Rearranged antigen receptor genes in Hodgkin's disease [published erratum appears in Blood 1987 Sep;70(3):893]

  1987cited by this paper
• Rearranged antigen receptor genes in Hodgkin's disease.

  1987cited by this paper
• Immunoglobulin gene rearrangements in Hodgkin's disease.

  1986cited by this paper
• Clonal analysis of T lymphocytes in spleens from patients with Hodgkin's disease. Frequent occurrence of unusual T4‐positive cells which co‐express cytolytic activity and production of interleukin‐2

  1986cited by this paper
• Capacity of B cells to function as stimulators of a primary mixed leukocyte reaction.

  1986cited by this paper
• Antigen-specific interaction between T and B cells

  1985cited by this paper
• Antigen presentation by Hodgkin's disease cells.

  1985cited by this paper
• Neoplastic cells obtained from Hodgkin's disease are potent stimulators of human primary mixed lymphocyte cultures.

  1983cited by this paper
• B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.

  1982cited by this paper
• Rosetting and other reactions of the Reed‐Sternberg cell

  1977cited by this paper
• Cellular Associations in Normal and Abnormal Lymphocytes (Illustrated by a Film)

  1959cited by this paper

• Microenvironment, crosstalk, and immune escape mechanisms

  2015cites this paper
• Analyse genetischer Läsionen im Hodgkin-Lymphom und einem Kombinationslymphom sowie Charakterisierung humaner CD30-positiver B-Zellen

  2015cites this paper
• The microenvironment in classical Hodgkin lymphoma: an actively shaped and essential tumor component.

  2014cites this paper
• with classical Hodgkin lymphoma from that of other diffuse large B-cell lymphomas and shares features The molecular signature of mediastinal large B-cell lymphoma differs

  2013cites this paper
• PML Nuclear Bodies and SATB1 Are Associated with HLA Class I Expression in EBV+ Hodgkin Lymphoma

  2013cites this paper
• Microenvironment, Cross-Talk, and Immune Escape Mechanisms

  2011cites this paper
• Molecular biology of Hodgkin lymphoma.

  2009cites this paper
• Composite EBV negative peripheral T-cell lymphoma and diffuse large B-cell lymphoma involving the ileum: A case report and a systematic review of the literature

  2006cites this paper
• Gene expression in Hodgkin lymphoma. The role of miR-155 in normal and malignant B cells

  2006cites this paper
• Is noise bad for your health?

  2005cites this paper
• The role of interleukin-3 in classical Hodgkin's disease

  2005cites this paper
• CD58 expression decreases as nonmalignant B cells mature in bone marrow and is frequently overexpressed in adult and pediatric precursor B-cell acute lymphoblastic leukemia.

  2005cites this paper
• Immune-mediated attack in relapsed Hodgkin's lymphoma.

  2005cites this paper
• Immune-mediated attack in relapsed Hodgkin's lymphoma

  2005cites this paper
• The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

  2003cites this paper
• Molecular biology of Hodgkin's lymphoma.

  2002cites this paper
• Expression of cytolytic lymphocyte-associated antigens in pulmonary lymphomatoid granulomatosis.

  2002cites this paper
• Dorothy Reed and Hodgkin's disease: a reflection after a century.

  2002cites this paper
• Expression of functional interleukin-3 receptors on Hodgkin and Reed-Sternberg cells.

  2002cites this paper
• Concurrent Hodgkin’s Disease (Mixed Cellularity Type) and T-Cell Chronic Lymphocytic Leukemia/Prolymphocytic Leukemia

  2001cites this paper
• [Hodgkin's disease: biology can help the physician towards new prognostic factors and new therapeutic approaches].

  2001cites this paper
• Differential modulation of immune recognition molecules by interleukin-7 in human acute leukaemias.

  1999cites this paper
• Soluble vascular cell adhesion molecule‐1 (sVCAM‐1) is an independent prognostic marker in Hodgkin's disease

  1998cites this paper
• Epstein-Barr virus in Hodgkin's disease.

  1998cites this paper
• Regulation of CD80/B7‐1 and CD86/B7‐2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition

  1998cites this paper
• Hodgkin’s disease: A disorder of dysregulated cellular cross-talk

  1998influential citation
• Reed-Sternberg cell: survival in a hostile sea.

  1998cites this paper
• In vivo expression of the CTLA4 inhibitory receptor in malignant and reactive cells from Human lymphomas

  1997cites this paper
• Hodgkin's disease: a tumor with disturbed immunological pathways.

  1997cites this paper
• Concurrent lymphocyte predominance Hodgkin's disease and T-cell lymphoma. A report of three cases.

  1996cites this paper
• Hodgkin's disease: a monoclonal lymphoproliferative disorder?

  1995cites this paper
• The microenvironment of Hodgkin lymphoma

  year unknowncites this paper